Suchergebnisse - "Palma, David"

PubPharm (19)

1

Determining Planning Priorities for SABR for Oligometastatic Disease : A Secondary Analysis of the SABR-COMET Phase II Randomized Trial

enthalten in: International journal of radiation oncology, biology, physics | 2022

von Van Oirschot, M. | Bergman, A. | Verbakel, W. | +15

2

Stereotactic Radiation for the Comprehensive Treatment of Oligometastases (SABR-COMET) : Extended Long-Term Outcomes

enthalten in: International journal of radiation oncology, biology, physics | 2022

von Harrow, S. | Palma, D. | Olson, R. | +19

CommentIn: Int J Radiat Oncol Biol Phys. 2022 Nov 15;114(4):561-570. - PMID 36244387

3

Assessment of Toxic Effects and Survival in Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma : The ORATOR2 Phase 2 Randomized Clinical Trial

enthalten in: JAMA oncology | 2022

von Palma, D. | Prisman, E. | Berthelet, E. | +46

CommentIn: JAMA Oncol. 2022 Jun 1;8(6):1-2. - PMID 35482361

4

Vocal-cord Only vs. Complete Laryngeal radiation (VOCAL) : a randomized multicentric Bayesian phase II trial

enthalten in: BMC cancer | 2021

von Bahig, H. | Rosenthal, D. | Nguyen-Tan, F. | +13

5

Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers : Long-Term Results of the SABR-COMET Phase II Randomized Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2020

von Palma, D. | Olson, R. | Harrow, S. | +21

CommentIn: Nat Rev Clin Oncol. 2020 Oct;17(10):593-594. - PMID 32699308

6

Treatment de-escalation for HPV-associated oropharyngeal squamous cell carcinoma with radiotherapy vs. trans-oral surgery (ORATOR2) : study protocol for a randomized phase II trial

enthalten in: BMC cancer | 2020

von Nichols, A. | Lang, P. | Prisman, E. | +47

7

Quality of Life Outcomes After Stereotactic Ablative Radiation Therapy (SABR) Versus Standard of Care Treatments in the Oligometastatic Setting : A Secondary Analysis of the SABR-COMET Randomized Trial

enthalten in: International journal of radiation oncology, biology, physics | 2019

von Olson, R. | Senan, S. | Harrow, S. | +19

8

Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR) : an open-label, phase 2, randomised trial

enthalten in: The Lancet. Oncology | 2019

von Nichols, A. | Theurer, J. | Prisman, E. | +30

CommentIn: Lancet Oncol. 2019 Oct;20(10):1328-1329. - PMID 31416686

9

Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer : Long-Term Results of a Multi-Institutional, Phase II, Randomized Study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2019

von Gomez, D. | Tang, C. | Zhang, J. | +18

CommentIn: Nat Rev Clin Oncol. 2019 Aug;16(8):466. - PMID 31123347

10

Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET) : a randomised, phase 2, open-label trial

enthalten in: Lancet (London, England) | 2019

von Palma, D. | Olson, R. | Harrow, S. | +19

CommentIn: Lancet. 2019 May 18;393(10185):2013-2014. - PMID 30982688